CalciMedica's Series C - II Round

CalciMedica raised a round of funding on December 18, 2009.

CalciMedica is dedicated to the discovery and development of novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. CalciMedica's drug di…

Articles about CalciMedica's Series C - II Round: